Transgenic and Knockout Mouse Resource
转基因和基因敲除小鼠资源
基本信息
- 批准号:7826899
- 负责人:
- 金额:$ 4.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AccountingAdvanced Malignant NeoplasmAnimal ModelBiologicalCancer CenterConsultCost SavingsDerivation procedureES Cell LineEmbryoEtiologyFoundationsFutureGene TargetingGenesGoalsHumanJournalsKnockout MiceMalignant NeoplasmsMicroinjectionsMolecularMusMutatePathogenesisPeer ReviewPlantsProductionPublicationsReagentResearchResearch PersonnelResource SharingResourcesRoleScientific Advances and AccomplishmentsServicesStem Cell ResearchStem cellsSystemTechnologyTransgenic OrganismsUniversitiesanticancer researchblastocystcostembryonic stem cellin vivomedical schoolsmembermouse genomemouse modelprogramssomatic cell nuclear transfertool
项目摘要
The Transgenic and Knockout Mouse Shared Resource was established in 1996 at the School of
Medicine. The overall objective of this Shared Resource is to provide genetically modified mouse
models and supporting technologies to Stanford Cancer Center investigators at cost-effective rates. This
Shared Resource provides the necessary scientific and technical foundation and physical plant to
conduct transgenic, gene targeting and embryonic stem cell research. The Shared Resource serves an
important role in advancing cancer research by providing a wide spectrum of mouse embryo and stem
cell manipulation and microinjection services to investigators as a highly specialized technology. The
objectives of the Shared Resource are to:
¿ Consult in all aspects of creating and characterizing genetically modified mice
¿ Produce transgenic and knockout mice by microinjection
¿ Manipulate mouse embryonic stem cells for gene targeting
¿ Provide molecular and biological reagents associated with production of genetically modified mice
Substantial cost savings, efficiencies and scientific advances accrue from providing these services
through a centralized facility. The Shared Resource has generated over 500 mouse models in the last 5
years, each with multiple independent lines. The Shared Resource's services were acknowledged in
more than 50 publications in peer-reviewed journals. In fiscal year 2005, there were 192 service requests,
with Cancer Center members accounting for 56% of overall use. Cancer Center members representing
eight out of ten Programs utilized the Shared Resource. Future plans for the Shared Resource include
implementation of somatic cell nuclear transfer and tetraploid blastocyst complementation services, and
derivation of new ES cell lines.
转基因和淘汰鼠标共享资源于1996年在学校建立
医学。共享资源的总体目标是提供基因修饰的鼠标
以具有成本效益的价格为斯坦福大学中央研究人员提供支持
共享资源提供了必要的科学技术基础和物理工厂
进行转基因,基因靶向和胚胎干细胞研究
通过提供广泛的小鼠胚胎和茎来推进癌症研究中的重要作用
细胞操作和对研究人员的微观注射作为高度专业化的技术
共享资源的目标是:
挥之不去在创建和表征转基因小鼠的各个方面咨询
挥之不去通过微型生产转基因和淘汰小鼠
挥之不去操纵小鼠胚胎干细胞进行基因靶向
挥之不去提供与遗传改性小鼠的产生相关的分子和生物试剂分配
提供这些服务的大量成本节省,效率和科学进步
通过集中式设施。
几年,都有多个独立线路。
2005财年的同行评审期刊中有50多个出版物,有192个服务请求,
癌症中心成员占整体使用的56%。
十分之八的计划利用了共享资源。
实施体细胞核转移和四倍体胚泡竞争服务,以及
新ES细胞系的推导。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ruby Yanru Chen-Tsai其他文献
Ruby Yanru Chen-Tsai的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ruby Yanru Chen-Tsai', 18)}}的其他基金
Targeted Gene Insertion by Directed Evolution of ΦC31 Integrase for Therapeutic Gene Editing
通过 κC31 整合酶定向进化进行靶向基因插入,用于治疗性基因编辑
- 批准号:
9906961 - 财政年份:2020
- 资助金额:
$ 4.44万 - 项目类别:
Targeted Gene Insertion by Directed Evolution of æC31 Integrase for Therapeutic Gene Editing
通过 αC31 整合酶定向进化进行靶向基因插入,用于治疗性基因编辑
- 批准号:
10177096 - 财政年份:2020
- 资助金额:
$ 4.44万 - 项目类别:
Targeted Gene Insertion by Directed Evolution of æC31 Integrase for Therapeutic Gene Editing
通过 αC31 整合酶定向进化进行靶向基因插入,用于治疗性基因编辑
- 批准号:
10227267 - 财政年份:2020
- 资助金额:
$ 4.44万 - 项目类别:
Development of novel rat models for site-specific transgene integration
开发用于位点特异性转基因整合的新型大鼠模型
- 批准号:
8643473 - 财政年份:2014
- 资助金额:
$ 4.44万 - 项目类别:
相似海外基金
Toward Translation of an Immunotherapeutic Nanomedicine for Neuroblastoma
神经母细胞瘤免疫治疗纳米药物的转化
- 批准号:
10650873 - 财政年份:2022
- 资助金额:
$ 4.44万 - 项目类别:
Toward Translation of an Immunotherapeutic Nanomedicine for Neuroblastoma
神经母细胞瘤免疫治疗纳米药物的转化
- 批准号:
10529900 - 财政年份:2022
- 资助金额:
$ 4.44万 - 项目类别:
Use of Radiological Clips for Improving Quantitative Ultrasound Imaging
使用放射夹改善定量超声成像
- 批准号:
10202531 - 财政年份:2020
- 资助金额:
$ 4.44万 - 项目类别:
Use of Radiological Clips for Improving Quantitative Ultrasound Imaging
使用放射夹改善定量超声成像
- 批准号:
10615670 - 财政年份:2020
- 资助金额:
$ 4.44万 - 项目类别:
Use of Radiological Clips for Improving Quantitative Ultrasound Imaging
使用放射夹改善定量超声成像
- 批准号:
10400728 - 财政年份:2020
- 资助金额:
$ 4.44万 - 项目类别: